In tumor, we found that the expression of tumor ploidy, CTLA4, PD1, and B7-1 was significantly higher in patients with recurrence versus those without recurrence (Figure 5E), but there was no statistical significance found in immune score (Supplementary Figure 8H). Here, CD80 is linked to neoplasm.